Emcure Pharmaceuticals Limited has informed the Exchange regarding amendment of Code of Conduct for regulating, monitoring and reporting of Insider trading in the Securities of the Company and Code of Practices and Procedures for fair disclosure of Unpublished Price Sensitive Information